UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
News
UC San Diego Opens the Design and Innovation Building
As a billion-dollar research enterprise in the heart of one of the most densely concentrated innovation hubs in the nation, UC San Diego is a unique place where fresh ideas are translated into solutions to benef… […]
News
Elizabeth Villa Selected as 2021 HHMI Investigator
Biological Sciences Associate Professor Elizabeth Villa has been selected as a 2021 Howard Hughes Medical Institute (HHMI) Investigator. As one of 33 scientists chosen out of pool of more than 800, Villa will re… […]
News
Artificial Intelligence Could Be New Blueprint for Precision Drug Discovery
Researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval. Click here to view original post… […]
